Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
* Wspomniani autorzy wnieśli do projektu równy wkład.
Here, we describe a method to analyze changes in the initiation of mRNA translation of eukaryotic cells in response to stress conditions. This method is based on the velocity separation on sucrose gradients of translating ribosomes from non-translating ribosomes.
Precise control of mRNA translation is fundamental for eukaryotic cell homeostasis, particularly in response to physiological and pathological stress. Alterations of this program can lead to the growth of damaged cells, a hallmark of cancer development, or to premature cell death such as seen in neurodegenerative diseases. Much of what is known concerning the molecular basis for translational control has been obtained from polysome analysis using a density gradient fractionation system. This technique relies on ultracentrifugation of cytoplasmic extracts on a linear sucrose gradient. Once the spin is completed, the system allows fractionation and quantification of centrifuged zones corresponding to different translating ribosomes populations, thus resulting in a polysome profile. Changes in the polysome profile are indicative of changes or defects in translation initiation that occur in response to various types of stress. This technique also allows to assess the role of specific proteins on translation initiation, and to measure translational activity of specific mRNAs. Here we describe our protocol to perform polysome profiles in order to assess translation initiation of eukaryotic cells and tissues under either normal or stress growth conditions.
Eukaryotic cells constantly encounter a range of harmful physiological and environmental stress conditions that require a rapid adaptive cell response. Cell stress response involves a precise balance between anti-survival and pro-survival acting factors. Disrupting this balance can have irreversible consequences leading the development of human pathologies such as cancer and neurodegenerative diseases. During the first step of the stress response, cells activate pro-survival pathways that involve the coordinated control of changes in gene expression at the level of mRNA translation.
mRNA translation in eukaryotes is a complex cellular process that involves coordinated interactions between translation initiation factors (eIFs), specific RNA binding proteins (RBDs), and RNA molecules1. mRNA translation is divided into three distinct phases: initiation, elongation, and termination. Although all three phases are subject to regulatory mechanisms, translational control mechanisms target mostly the initiation phase of translation, which thus constitutes the rate-limiting step of protein synthesis2.
Translation initiation is a highly ordered process that begins with the formation of the eIF2a.GTP.Met-tRNAiMet ternary complex and its subsequent binding to the 40S ribosome subunit, leading to the formation of the pre-initiation complex. The next step is the recruitment of the preinitiation complex to mRNA, which involves the activity of translation initiation factors such as eIF4F and eIF3. The 48S preinitiation complex thus formed undergoes specific conformational changes that enable this machinery to start scanning the 5'-untranslated region of the mRNA until it recognizes the initiation codon AUG. Most of the translation initiation factors are then released and 60S subunits are recruited to form an 80S ribosome complex competent for translation, at which point protein synthesis starts (Figure 1). More than one 80S monosome can be translating the same mRNA at a time producing so called polysomes (or polyribosomes). The density of polysomes on a mRNA reflects the initiation, elongation and termination rates and thus is a measure of the translatability of a particular transcript. However, polysome profile is mainly used to assess changes in mRNA translation at the initiation step. Here we have used a proteasome inhibitor as translation initiation inhibitor. Treatment of cancer cells with this drug induces a stress response characterized by activation of the stress kinase named HRI which phosphorylates the translation initiation factor eIF2a3. Phosphorylation of eIF2a is one of the major events leading to the inhibition of translation initiation in mammalian cells4.
The protocol follows the guidelines approved by Laval's Ethical Review Board.
1. Preparation of Cell Cultures and Brain Manipulation
2. Preparation of the Density Gradient Fractionation System
3. Preparation of the Sucrose Gradients
4. Preparation of Cell and Mouse Brain Extracts
5. Loading the Extracts onto Sucrose Gradients and Ultracentrifugation
6. Fractionation of Cytoplasmic Extracts for Polysomes Profiling
7. Protein Extraction and Analysis
8. RNA Extraction and Analysis
As aforementioned, polysome profile allows the analysis of changes of translation initiation under stress conditions. Figure 1 is a simplified view of translation initiation which as described earlier is a multistep process involving an ordered assembly of translation initiation complexes. Under normal growth conditions, translation initiation complexes are converted into polyribosomes whose detection by polysome profile attest for an active translation initiation (Figure 2; Untreated). ...
The polysome profile analysis on sucrose gradients allows measurement of translation initiation by analyzing the density of polysomes isolated from cells or tissues9,11-14. This technique is the best (if not the unique) approach to measure translation initiation in vivo. It is used to monitor the translational status of growing cells during cell cycle15, and to assess the effects of various types of stress including viral infections, hypoxia13,16, radiation17, and chem...
The authors have nothing to disclose.
P. A. is a recipient of a scholarship "Pierre Durand" from the Faculty of medicine of Laval University. This work was supported by the Natural Sciences and Engineering Research Council of Canada (MOP-CG095386) to R. M. The polysome fractionator was acquired through a Canadian Foundation for innovation grant (MOP-GF091050) to R. M. R. M holds a new CIHR investigator salary award.
We are grateful to Drs. E. Khandjian, I. Gallouzi, S. Di-Marco and A. Cammas for helpful advice.
Name | Company | Catalog Number | Comments |
Cells | |||
HeLa cervical cancer cells | American Type Culture Collection (Manassas, VA; ATCC) | CCL-2 | |
Schneider Drosophila embryonic cells | American Type Culture Collection (Manassas, VA; ATCC) | CRL-1963 | |
Culture medium and Supplements | |||
Schneider’s Drosophila Medium | Sigma-Aldrich | SO146-500ml | |
DMEM | Life technologies | 11995-073 | |
FBS | Fisher Scientist Scientist | SH30396-03 | |
Penicillin/streptomycin | Life technologies | 15140122 | |
Sucrose solutions | |||
D-sucrose | Fisher Scientist | BP220-212 | |
Glycerol | Sigma-Aldrich | 49767 | |
Bromophenol blue | Fisher Scientist | B3925 | |
Lysis buffer | |||
Tris HCl | Fisher Scientist | BP153-500 | |
MgCl2 | Sigma-Aldrich | M2670-100G | |
NaCl | Tekniscience | 3624-05 | |
DTT | Sigma-Aldrich | D 9779 | |
Nonidet P40 (Igepal CA-630 ) | MJS Biolynx | 19628 | |
SDS | Tekniscience | 4095-02 | |
RNase inhibitor (RnaseOUT Recombinant Ribonuclease Inhibitor) | Life technologies | 10777-019 | |
Antiproteases (complete, mini, EDTA free) | Roche | 11,836,170,001 | |
RNA Extraction | |||
Proteinase K | Life technologies | AM2542 | |
Phenol:chloroform | Fisher Scientist | BP1754I-400 | |
Chloroform | Fisher Scientist | C298-500 | |
Glycogen | Life technologies | 10814-010 | |
Isopropanol | Acros organics | 327270010 | |
Antibodies | |||
anti-FMRP antibody | Fournier et al., Cancer Cell International, 2010 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone